[The value of biphosphonates in the therapy of prostate cancer].
Skeletal complications of bone metastases or secondary osteoporosis are a frequent event in patients with prostate cancer. Bisphosphonates have been widely used for both indications because of their capacity to prevent bone loss, to reduce pain and to inhibit metastatic growth. Possible side effects include acute phase reactions, osteonecrosis of the jaw and renal impairment. Therefore, the risks and benefits of therapy should be considered and informed consent obtained from the patient. Given current evidence the guidelines only allow a recommendation for use in patients with metastatic prostate cancer.
Rolfes
N
N
Abteilung für Urologie, Kinderurologie und Uro-Onkologie, St. Josef-Hospital, Hospitalstrasse 45, 53840, Troisdorf, Germany. norbert.rolfes@josef-hospital.de
Lümmen
G
G
D000970:Antineoplastic Agents / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D002277:Carcinoma / Q000188:drug therapy* / Q000556:secondary*; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D050071:Bone Density Conservation Agents; D004164:Diphosphonates
J Urol. 2003 Jun;169(6):2008-12
12771706
J Urol. 2006 Dec;176(6 Pt 2):S50-4
17084167
Cancer Invest. 2009 Feb;27(2):221-6
19235596
Cancer. 2007 Mar 15;109(6):1090-6
17311345
J Clin Oncol. 2008 Sep 20;26(27):4426-34
18802155
Cancer. 1997 Oct 15;80(8 Suppl):1588-94
9362426
J Clin Invest. 1996 Aug 1;98(3):698-705
8698861
J Urol. 2002 Feb;167(2 Pt 1):535-8
11792913
N Engl J Med. 2005 Jan 13;352(2):154-64
15647578
J Urol. 2002 May;167(5):1952-6
11956415
Cancer Res. 2001 Mar 15;61(6):2602-8
11289137
Gerontology. 2006;52(2):107-10
16508318
Cell Biol Int. 2009 Feb;33(2):239-46
19103299
J Natl Cancer Inst. 2002 Oct 2;94(19):1458-68
12359855
J Oral Maxillofac Surg. 2009 Jul;67(7):1363-72
19531404
Eur Urol. 2004 Dec;46(6):731-39; discussion 739-40
15548440
BMJ. 2003 Aug 30;327(7413):469
12946966
Eur Urol. 2008 Nov;54(5):1066-72
18602738
Eur Urol. 2006 Mar;49(3):429-40
16431012
Aktuelle Urol. 2009 May;40(3):169-70
19479669